Your browser doesn't support javascript.
loading
Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2.
Perrier-Trudova, Victoria; Huimin, Bernice Wong; Kongpetch, Sarinya; Huang, Dachuan; Ong, Pauline; Le Formal, Audrey; Poon, Song Ling; Siew, Ee Yan; Myint, Swe Swe; Gad, Sophie; Gardie, Betty; Couvé, Sophie; Foong, Yu Miin; Choudhury, Yukti; Poh, Jonathan; Ong, Choon Kiat; Toh, Chee Keong; Ooi, Aikseng; Richard, Stéphane; Tan, Min-Han; Teh, Bin Tean.
Afiliación
  • Perrier-Trudova V; Ecole Pratique des Hautes Etudes, Paris and French National Institute of Health and Medical Research U753, Gustave Roussy Cancer Campus, Villejuif, France Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore.
  • Huimin BW; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore Division of Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Republic of Singapore.
  • Kongpetch S; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore.
  • Huang D; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore.
  • Ong P; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore Division of Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Republic of Singapore.
  • Le Formal A; Ecole Pratique des Hautes Etudes, Paris and French National Institute of Health and Medical Research U753, Gustave Roussy Cancer Campus, Villejuif, France.
  • Poon SL; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore Division of Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Republic of Singapore.
  • Siew EY; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore.
  • Myint SS; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore.
  • Gad S; Ecole Pratique des Hautes Etudes, Paris and French National Institute of Health and Medical Research U753, Gustave Roussy Cancer Campus, Villejuif, France.
  • Gardie B; French National Institute of Health and Medical Research U892 and French National Centre for Scientific Research 6299, Cancer Research Center Nantes-Angers, University of Nantes, Nantes, France.
  • Couvé S; Ecole Pratique des Hautes Etudes, Paris and French National Institute of Health and Medical Research U753, Gustave Roussy Cancer Campus, Villejuif, France.
  • Foong YM; Department of Biodevices and Diagnostics, Institute of Bioengineering and Nanotechnology, Singapore, Republic of Singapore.
  • Choudhury Y; Department of Biodevices and Diagnostics, Institute of Bioengineering and Nanotechnology, Singapore, Republic of Singapore.
  • Poh J; Department of Biodevices and Diagnostics, Institute of Bioengineering and Nanotechnology, Singapore, Republic of Singapore.
  • Ong CK; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore Division of Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Republic of Singapore.
  • Toh CK; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Republic of Singapore.
  • Ooi A; Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Arizona, AZ, U.S.A.
  • Richard S; Ecole Pratique des Hautes Etudes, Paris and French National Institute of Health and Medical Research U753, Gustave Roussy Cancer Campus, Villejuif, France Faculty of Medicine, Paris-Sud University, Kremlin Bicêtre, Paris, France.
  • Tan MH; Department of Biodevices and Diagnostics, Institute of Bioengineering and Nanotechnology, Singapore, Republic of Singapore Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Republic of Singapore minhan.tan@gmail.com teh.bin.tean@singhealth.com.sg.
  • Teh BT; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Republic of Singapore Division of Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Republic of Singapore minhan.tan@gmail.com teh.bin.tean@singhealth.com.sg.
Anticancer Res ; 35(12): 6639-53, 2015 Dec.
Article en En | MEDLINE | ID: mdl-26637880
Asunto(s)
Palabras clave
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_energeticas / Bioenergetica Asunto principal: Carcinoma de Células Renales / Fumarato Hidratasa Tipo de estudio: Prognostic_studies Idioma: En Revista: Anticancer Res Año: 2015 Tipo del documento: Article
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_energeticas / Bioenergetica Asunto principal: Carcinoma de Células Renales / Fumarato Hidratasa Tipo de estudio: Prognostic_studies Idioma: En Revista: Anticancer Res Año: 2015 Tipo del documento: Article